Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CareCloudCCLD +1.24%50 EV-to-EBIT is 10.33 as of Aug. 03, 2026. GuruFocus rates CCLD with a GF Score™ of 50/100 and a GF Value™ of $1.06 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 470 Healthcare Providers & Services companies, CareCloud ranks better than 73.19% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
CareCloud's Enterprise Value for the quarter that ended in Mar. 2026 was $157.5 Mil.
CareCloud's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $10.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CareCloud EV-to-EBIT Related Terms
CareCloud EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for CareCloud's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, CareCloud's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CareCloud EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, CareCloud's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where CareCloud's EV-to-EBIT falls into.
CareCloud's current Enterprise Value is $106.1 Mil.
CareCloud's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $10.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CareCloud (CCLD) has a EV-to-EBIT of 10.33 as of Aug. 03, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on CareCloud and its competitors. According to the industry distribution chart, CareCloud ranks #126 out of 470 companies in the Healthcare Providers & Services industry, placing it in the top 26.8%.
Is CareCloud's EV-to-EBIT too high?
CareCloud's current EV-to-EBIT is 10.33. The Healthcare Providers & Services industry median EV-to-EBIT is 15.85. CareCloud's value of 10.33 is 34.8% below this industry median. Based on the distribution chart, CareCloud ranks #126 out of 470 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, CareCloud has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does CareCloud's EV-to-EBIT compare to DH and OPRX?
According to the Healthcare Providers & Services industry distribution chart, CareCloud ranks #126 out of 470 companies for EV-to-EBIT. This puts CareCloud in the upper half of its industry. The industry median EV-to-EBIT is 15.85. CareCloud's value of 10.33 is 34.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.85, based on 470 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CareCloud's current EV-to-EBIT of 10.33 is 34.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on CareCloud and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CareCloud's current EV-to-EBIT is 10.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CareCloud stock overvalued right now?
Based on GuruFocus' analysis, CareCloud (CCLD) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.06, compared to a current price of $2.44 — trading 130.2% above its estimated fair value. The current EV-to-EBIT is 10.33 and 34.8% below the Healthcare Providers & Services industry median of 15.85. CareCloud's overall GF Score™ is 50/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For CareCloud (CCLD), the current EV-to-EBIT is 10.33 as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CareCloud (CCLD) Overvalued in 2026?
Based on GuruFocus' analysis, CareCloud stock appears to be overvalued.
The current stock price of $2.44 is trading 130.2% above its estimated GF Value™ of $1.06.
GuruFocus considers CareCloud to be Significantly Overvalued.
Key valuation signals for CCLD:
EV-to-EBIT: 10.33
GF Value™: $1.06 vs. price of $2.44 (130.2% above fair value)
Industry Position: 34.8% below the Healthcare Providers & Services median (#126 of 470)
No single metric tells the full story. See the CCLD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CareCloud Inc delivers flexible, tech-enabled solutions for healthcare providers of all sizes and multi-specialties across the U.S. It is a healthcare technology company offering cloud-based solutions that simplify clinical, administrative, and financial workflows for medical practices of all sizes. Its comprehensive suite includes Electronic Health Records (EHRs), Practice Management, Revenue Cycle Management (RCM), Medical Billing, Telehealth, and Patient Experience solutions. The group helps practices increase efficiency, improve patient care, and drive sustainable growth-all while ensuring HIPAA compliance and seamless integration. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.
50GF Score
Get the complete analysis for CCLD
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CCLD has been successfully added to your 
